Evidence map›Paper›PMID 38409433›Full record

ArticleAnnals of biomedical engineering2024

Quantitative and Visual Analysis of Data Augmentation and Hyperparameter Optimization in Deep Learning-Based Segmentation of Low-Grade Glioma Tumors Using Grad-CAM.

Fereshteh Khodadadi Shoushtari, Azimeh N V Dehkordi, Sedigheh Sina

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of biomedical engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Fereshteh Khodadadi ShoushtariNuclear Engineering Department, Shiraz University, Shiraz, Iran.
Azimeh N V DehkordiDepartment of Physics, Faculty of Computer Engineering, Najafabad Branch, Islamic Azad University, Najafabad, Iran. noorizadeh.az@gmail.com.ORCID http://orcid.org/0000-0001-6824-2944
Sedigheh SinaNuclear Engineering Department, Shiraz University, Shiraz, Iran.
Shiraz University · IRIslamic Azad University of Najafabad · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study executes a quantitative and visual investigation on the effectiveness of data augmentation and hyperparameter optimization on the accuracy of deep learning-based segmentation of LGG tumors. The study employed the MobileNetV2 and ResNet backbones with atrous convolution in DeepLabV3+ structure. The Grad-CAM tool was also used to interpret the effect of augmentation and network optimization on segmentation performance. A wide investigation was performed to optimize the network hyperparameters. In addition, the study examined 35 different models to evaluate different data augmentation techniques. The results of the study indicated that incorporating data augmentation techniques and optimization can improve the performance of segmenting brain LGG tumors up to 10%. Our extensive investigation of the data augmentation techniques indicated that enlargement of data from 90° and 225° rotated data,up to down and left to right flipping are the most effective techniques. MobilenetV2 as the backbone,"Focal Loss" as the loss function and "Adam" as the optimizer showed the superior results. The optimal model (DLG-Net) achieved an overall accuracy of 96.1% with a loss value of 0.006. Specifically, the segmentation performance for Whole Tumor (WT), Tumor Core (TC), and Enhanced Tumor (ET) reached a Dice Similarity Coefficient (DSC) of 89.4%, 70.1%, and 49.9%, respectively. Simultaneous visual and quantitative assessment of data augmentation and network optimization can lead to an optimal model with a reasonable performance in segmenting the LGG tumors.

Indexed as

Brain NeoplasmsDeep LearningGliomaHumansImage Processing, Computer-AssistedAugmentationDeepLabV3+Grad-CAMLow-grade gliomaTumor segmentation

Identifiers

PMID38409433
OpenAlexW4392153649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.